Antibiotice S.A. (BVB:ATB)
2.395
-0.005 (-0.21%)
At close: Dec 5, 2025
Antibiotice Cash Flow Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 56.9 | 102.2 | 81.09 | 51.47 | 29.94 | 26.39 | Upgrade
|
| Depreciation & Amortization | 66.47 | 45.06 | 27.93 | 22.57 | 24.43 | 22.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | 7.51 | -0.16 | -0 | 2.75 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 3.04 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -2.99 | 3 | -1.1 | -3.14 | - | - | Upgrade
|
| Other Operating Activities | -6.97 | -6.57 | 2.81 | 17.4 | -9.93 | 45.56 | Upgrade
|
| Change in Accounts Receivable | -100.83 | -65.3 | -30.64 | 75.98 | - | - | Upgrade
|
| Change in Inventory | -17.69 | -1.78 | -19.05 | -40.84 | - | - | Upgrade
|
| Change in Unearned Revenue | 0.16 | 0.16 | 0 | 0.03 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 47.77 | 18.54 | 61.42 | -13.6 | - | - | Upgrade
|
| Operating Cash Flow | 50.34 | 95.15 | 122.46 | 115.66 | 44.44 | 94.05 | Upgrade
|
| Operating Cash Flow Growth | -64.19% | -22.30% | 5.88% | 160.28% | -52.75% | 356.00% | Upgrade
|
| Capital Expenditures | -139.03 | -98.77 | -83.03 | -37.58 | -29.05 | -47.99 | Upgrade
|
| Sale (Purchase) of Intangibles | -54.31 | -17.39 | -15.01 | -7.47 | - | - | Upgrade
|
| Investing Cash Flow | -193.34 | -116.16 | -98.04 | -45.05 | -29.05 | -47.99 | Upgrade
|
| Long-Term Debt Issued | - | 85.19 | - | - | - | 16.31 | Upgrade
|
| Long-Term Debt Repaid | - | -10.79 | -14.68 | -63.8 | -6.32 | - | Upgrade
|
| Total Debt Repaid | -10.79 | -10.79 | -14.68 | -63.8 | -6.32 | - | Upgrade
|
| Net Debt Issued (Repaid) | 159.92 | 74.41 | -14.68 | -63.8 | -6.32 | 16.31 | Upgrade
|
| Common Dividends Paid | -27.02 | -48.17 | -5.43 | -3.43 | -2.1 | -18.17 | Upgrade
|
| Other Financing Activities | -4.61 | -4.61 | -4.09 | -3.53 | - | -0 | Upgrade
|
| Financing Cash Flow | 128.3 | 21.63 | -24.2 | -70.76 | -8.42 | -1.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.25 | 0.25 | -0.14 | -0.26 | -0.1 | -1.4 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | 0.02 | - | - | Upgrade
|
| Net Cash Flow | -14.45 | 0.87 | 0.08 | -0.38 | 6.87 | 42.81 | Upgrade
|
| Free Cash Flow | -88.7 | -3.63 | 39.43 | 78.09 | 15.39 | 46.06 | Upgrade
|
| Free Cash Flow Growth | - | - | -49.50% | 407.53% | -66.60% | - | Upgrade
|
| Free Cash Flow Margin | -13.67% | -0.53% | 6.41% | 15.46% | 4.06% | 13.27% | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.01 | 0.06 | 0.12 | 0.02 | 0.07 | Upgrade
|
| Cash Interest Paid | 4.58 | 4.61 | 4.09 | 3.53 | 3.54 | 5.06 | Upgrade
|
| Cash Income Tax Paid | 7.34 | 3.72 | 13.02 | 3.93 | 3.61 | 2.28 | Upgrade
|
| Levered Free Cash Flow | -251.78 | -60.04 | -6 | 44.45 | 21.61 | 40.65 | Upgrade
|
| Unlevered Free Cash Flow | -248.96 | -57.2 | -3.4 | 46.69 | 23.81 | 43.74 | Upgrade
|
| Change in Working Capital | -70.59 | -48.38 | 11.73 | 21.57 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.